Board of Directors

The composition of Novozymes' Board of Directors following the Annual Shareholders' Meeting on February 24, 2016.

  • bod-HenrikGurtler-2014
    Henrik GürtlerBorn 1953. MSc (Engineering), chemical engineer. Chairman of the Board since 2000. Elected for one year at a time.

    Board positions
    Member: Ejendomsmægler Kim Svane A/S

    Special competencies
    In-depth knowledge of Novozymes’ business, and expertise in managing and working in an international biotechnology company.
  • bod-JorgenBuhl-2014
    Jørgen Buhl RasmussenBorn 1955. MSc (Economics and Business Administration), MBA. Adjunct professor at Copenhagen Business School. Member of the Board since 2011. Member of the Audit Committee. Elected for one year at a time.
     
    Board positions
    Member: IFC Europe A/S, Axcel Advisory Board, DI's Permanent Committee on Business Policies
     
    Special competencies
    International business and management experience, specifically within sales, marketing, branding and acquisitions.
  • Heinz_Jurgen-new
    Heinz-Jürgen BertramBorn 1958. President & CEO, Symrise AG, Germany. Doctoral degree, PhD (Chemistry). Member of the Board since 2015. Elected for one year at a time. 

    Board positions
    Member: Rockwool International A/S
     
    Special competencies
    International business and management experience, specifically converting research and biotechnology into commercial products and solutions.
  • bod-LGR-2014
    Lars GreenBorn 1967. Senior Vice President, Finance & Operations, Novo Nordisk Inc. (USA), MSc (Business Administration). Member of the Board since 2014. Chairman of the Audit Committee. Elected for one year at a time.
     
    Board positions
    None
     
    Special competencies
    In-depth knowledge of the Novo Group's business, international experience from managing global biotech and biopharma companies, and financial and accounting expertise.
  • bod-AgneteRaaschou-2014
    Agnete Raaschou-NielsenBorn 1957.

    PhD (Economics). Vice Chairman. Member of the Board since 2011. Member of the Audit Committee. Elected for one year at a time.

    Board positions
    Chairman: Arkil Holding A/S, Brdr. Hartmann A/S
    Vice Chairman: Dalhoff Larsen & Horneman A/S, Danske Invest, Solar A/S
    Member: Aktieselskabet Schouw & Co., Danske Invest Management A/S, Icopal Holding A/S

    Member of Audit Committees:
    Aktieselskabet Schouw & Co., Solar A/S

    Special competencies
    Expertise in business development and acquisitions, macroeconomics and intellectual property rights.

  • bod-MathiasUhlen-2014
    Mathias UhlénBorn 1954. Professor, the Royal Institute of Technology (Kungliga Tekniska Högskolan), Sweden, and the Technical University of Denmark (DTU). Member of the Board since 2007. Elected for one year at a time.

    Board positions
    Chairman: Atlas Antibodies AB, Antibodypedia AB
    Vice Chairman: Affibody AB
    Member: Alligator AB, Bure Equity AB, SweTree Technologies AB
     
    Special competencies
    Broad experience in research and biotechnology.
  • bod-LenaBech-2014
    Lena Bech HolskovBorn 1967. Safety Adviser. Employee representative. Member of the Board since 2013. Elected for four years at a time.
  • bod-AndersHentze-2014
    Anders Hentze KnudsenBorn 1959. Senior Operator. Employee representative. Member of the Board since 2013. Elected for four years at a time.
  • bod-LarsBoKoppler-2014
    Lars Bo KøpplerBorn 1962. Technician. Employee representative. Member of the Board since 2010. Elected for four years at a time.
     
    Employee elected member of the board of Novo Nordisk Foundation since 2014. Elected for a four year period.